Insider Selling: CME Group Inc. (NASDAQ:CME) Insider Sells 1,374 Shares of Stock

CME Group Inc. (NASDAQ:CME) insider Timothy Francis Mccourt sold 1,374 shares of the business’s stock in a transaction that occurred on Monday, October 28th. The shares were sold at an average price of $227.12, for a total value of $312,062.88. Following the completion of the sale, the insider now owns 7,275 shares of the company’s stock, valued at $1,652,298. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

CME Group Stock Down 0.5 %

Shares of NASDAQ:CME opened at $227.09 on Wednesday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. The business has a fifty day moving average of $219.69 and a two-hundred day moving average of $209.10. The stock has a market cap of $81.77 billion, a P/E ratio of 25.84, a PEG ratio of 7.76 and a beta of 0.55. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $230.36.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The company’s revenue was up 18.4% compared to the same quarter last year. During the same period in the prior year, the business posted $2.25 EPS. On average, research analysts expect that CME Group Inc. will post 10.04 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were issued a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.03%. The ex-dividend date of this dividend was Monday, September 9th. CME Group’s dividend payout ratio is presently 52.33%.

Hedge Funds Weigh In On CME Group

Hedge funds have recently modified their holdings of the business. Capital International Investors boosted its holdings in CME Group by 24.1% during the 1st quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after acquiring an additional 3,069,806 shares during the period. Ameriprise Financial Inc. boosted its holdings in CME Group by 11.3% during the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock valued at $1,038,676,000 after acquiring an additional 537,758 shares during the period. GUARDCAP ASSET MANAGEMENT Ltd boosted its holdings in CME Group by 1.1% during the 1st quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 4,009,068 shares of the financial services provider’s stock valued at $863,112,000 after acquiring an additional 43,293 shares during the period. Raymond James & Associates boosted its holdings in CME Group by 3.2% during the 2nd quarter. Raymond James & Associates now owns 3,029,145 shares of the financial services provider’s stock valued at $595,530,000 after acquiring an additional 94,302 shares during the period. Finally, Legal & General Group Plc boosted its holdings in CME Group by 6.6% during the 2nd quarter. Legal & General Group Plc now owns 2,835,075 shares of the financial services provider’s stock valued at $557,371,000 after acquiring an additional 176,004 shares during the period. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

CME has been the subject of several research reports. JPMorgan Chase & Co. boosted their price target on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research report on Thursday, July 25th. Bank of America boosted their price target on CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a research report on Thursday, October 3rd. Morgan Stanley boosted their price target on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 17th. The Goldman Sachs Group boosted their price target on CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research report on Thursday, October 3rd. Finally, Citigroup boosted their price target on CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a research report on Thursday, October 24th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $222.73.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.